Gujarat Themis Biosyn shareholding pattern

·Pharma & Health Chart ›

Who owns itSep 2026 quarter

Promoters59.33%−11.53 pts

Foreign investors (FII)3.80%+2.03 pts

Domestic institutions (DII)12.65%+11.47 pts

of which mutual funds9.63%+8.47 pts

of which insurance companies2.17%

Public24.22%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GUJTHEM₹355.55

Gujarat Themis Biosyn Limited

· Pharma & Health

₹ CrorePeersRPGLIFE GUFICBIO ORCHPHARMA UNICHEMLAB FDC IOLCP MOREPENLAB INNOVACAPMcap ₹3,874 Cr

Holding % of Total Shares 12 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	70.86	70.86	70.86	70.86	70.86	70.86	59.33
FII / FPI	1.91	2.51	2.95	1.96	1.80	1.77	3.80
DII	1.17	1.17	1.17	1.17	1.18	1.18	12.65
Mutual Funds	1.16	1.16	1.16	1.16	1.16	1.16	9.63

Latest: 2026-09-30 · 9 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.